Skip to main content

Table 3 1-year and 2-years percentage for investigated clinical outcomes

From: Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis

Outcome

1 year

2 years

OS

88.9%

88.9%

LC

88.9%

66.7%

DPFS

53.1%

53.1%

BRFS

88.9%

66.7%

  1. OS: overall survival; LC: local control; DPFS: disease progression free survival; BRFS: biochemical relapse free survival
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us